Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
EGFR inhibition in the treatment of non-small cell lung cancer
David E. Gerber
Hematology & Oncology
Internal Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
49
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'EGFR inhibition in the treatment of non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
ErbB Receptors
100%
Non-Small Cell Lung Carcinoma
93%
Protein-Tyrosine Kinases
68%
Cetuximab
37%
Panitumumab
22%
Lapatinib
21%
Erlotinib Hydrochloride
19%
Gefitinib
18%
Drug Therapy
17%
Therapeutics
17%
Receptor Protein-Tyrosine Kinases
16%
Non-Smokers
15%
Combination Drug Therapy
15%
Pharmaceutical Preparations
12%
Histology
11%
Adenocarcinoma
11%
Radiation
11%
Monoclonal Antibodies
10%
Ligands
10%
Radiotherapy
10%
Mutation
8%
Survival
8%
Population
5%
Neoplasms
4%
Chemical Compounds
Tyrosine Kinase Inhibitor
97%
Tyrosine
31%
Lapatinib
29%
Gefitinib
27%
Erlotinib
27%
Oncogenic
24%
Signalling Molecule
21%
Growth Factor
20%
Drug
18%
Mutation
14%
Resistance
10%